Precision medicine

A tumor gene test has been developed that may predict poor survival in patients with ovarian cancer

To improve immunotherapy outcomes, we need to explore new biomarkers that offer spatial resolution in the tumor microenvironment

Two experts in childhood cancers give their take on the intricacies of pediatric laboratory medicine and where they think the field will go next

As the UK heads toward test centralization, medical oncologist Tanya Ahmad explains why in-house testing shouldn’t be left behind

A new algorithm may help identify rare circulating tumor cells to improve liquid biopsy

New AI technology uses H&E images to create an alternative path for molecular diagnostics

Liquid biopsy is minimally invasive and easily accessible – but what information can a new multiplexed assay provide from circulating tumor DNA?

Minimal residual disease testing by immunosequencing can yield vital information about patients’ disease and management

In-house testing offers labs the ability to research, educate, and achieve complete coordination with clinical colleagues

A comparison of commonly used NGS assays for the detection of fusion genes based on a recent educational webinar